Diligence memo · auto-generated · as of July 3, 2026

Panama City Surgery Center, LLC

Panama City Surgery Center, LLC looks fair against its niche peers and is active on financing cadence.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

Panama City Surgery Center, LLC operates in Other Health Care, based in PANAMA CITY.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Panama City Surgery Center, LLC has raised $1.3M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $667K on 2024-05-02.

Most recent recorded round closed around 2025-04-30.

Valuation (modeled)modeled

Provath models Panama City Surgery Center, LLC at approximately $853K (range $191K–$2.2M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.03× the median modeled value of Pre-Seed Other Health Care companies in 2025–2027 (116 peers) — value vs value, same stage and era. Within the normal band (103% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 13 months.

Last raise 14 mo ago; this sector typically re-raises about every 14 months.

Raising on or ahead of the sector's normal rhythm.

The last round was 2.2× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 39% of Other Health Care peers (5377 compared).

Modeled value ranks above 5% of those peers.

Closest niche peers: 352 Ingredients LLC, Bmh North Mississippi Imaging Services Llc, ClearPath Vascular, Inc., Imagen Silvera Support Services, LLC, Mens LLC.

Peoplefiled

16 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.